Clinical, immunologic, and technical factors affecting recovery of platelet count after platelet transfusion [8]

Haematologica

Volumn 87, Issue 8, 2002, Pages 893-894

  Inverardi, Daniela ^a   Bocchio, Chiara ^a   Rossi, Lucia ^a   Mazzucco, Laura ^a   De Paoli, Lorella ^a   Borzini, Piero ^a  

^a C Arrigo Children's Hospital   (Italy)

Author keywords

Compatible platelets; Corrected count increment; Detrimental factors; Platelet transfusion; Refractoriness

Indexed keywords

AUTOANTIBODY; THROMBOCYTE ANTIBODY; THROMBOCYTE CONCENTRATE; ALLOANTIBODY; THROMBOCYTE ANTIGEN;

ALLOIMMUNITY; APHERESIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; BLOOD; BLOOD STORAGE; CELL SEPARATION; IMMUNIZATION; IMMUNOLOGY; METHODOLOGY; PRECIPITATION; PROSPECTIVE STUDY; THROMBOCYTOPENIA; THROMBOCYTOPHERESIS; TIME;

ANTIGENS, HUMAN PLATELET; BLOOD PRESERVATION; CELL SEPARATION; HUMAN; IMMUNIZATION; ISOANTIBODIES; PLATELET COUNT; PLATELET TRANSFUSION; PLATELETPHERESIS; PRECIPITATION; PROSPECTIVE STUDIES; THROMBOCYTOPENIA; TIME FACTORS; HUMANS;

EID: 0035986795     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. The evaluation and management of platelet refractoriness and alloimmunization
2. Alloimmune platelet refractoriness: Incidence declines, unsolved problems persist
3. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets
4. Diagnosis and management of refractoriness to platelet transfusion
5. + LD, and filtered pooled buffy-coatderived platelets
6. Storage pool defect in pooled buffy coat platelet concentrates within the shelf-life period
7. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The trial to reduce alloimmunization to platelets study group